-
Olmesartan, Angiotensin II Type 1 Receptor Blocker, Induced Prolonged Survival of Murine Cardiac Allografts and Generated Regulatory Cells
-
Once-Daily Extended-Release Formulation of Tacrolimus Does Not Require Double Dose of Twice-Daily Formulation of Tacrolimus in Kidney Transplantation
-
One Year Results of the Effects of Rituximab on Acute Humoral Rejection in Renal Transplantation: RITUX ERAH, a Multicenter Randomized Placebo Controlled Trial
-
One-Shot Versus Standard Perioperative Antibiotic Prophylaxis after Kidney Transplantation: Results from a Prospective Randomized Multicenter Study
-
Open-Label Study of Planned Transition from Tacrolimus to Sirolimus vs Continued Tacrolimus in Renal Allograft Recipients: Demographics and Interim Safety Results
-
Opportunities for Expanding the Deceased Donor Pool in an Era of Outcomes-Driven Health Care
-
Opposing Roles of TIM-4 on Dendritic Cells vs Macrophages in Transplant Rejection
-
Optimization of the Coating of Pancreatic Islets with T Regulatory Cells in the Novel Immunoprotective Approach
-
Optimizing Kidney Exchange with Transplant Chains: Theory and Reality
-
Opting Out: Confidentiality & Alibis for Living Kidney Donors
- « Previous Page
- 1
- …
- 118
- 119
- 120
- 121
- 122
- …
- 178
- Next Page »